Mackay Shields LLC’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-62,085
| Closed | -$3.73M | – | 1570 |
|
2020
Q3 | $3.73M | Sell |
62,085
-11,900
| -16% | -$715K | 0.03% | 519 |
|
2020
Q2 | $3.88M | Sell |
73,985
-6,400
| -8% | -$336K | 0.03% | 488 |
|
2020
Q1 | $2.7M | Sell |
80,385
-6,800
| -8% | -$228K | 0.02% | 545 |
|
2019
Q4 | $3.95M | Sell |
87,185
-20,800
| -19% | -$942K | 0.03% | 561 |
|
2019
Q3 | $4.11M | Buy |
107,985
+10,100
| +10% | +$385K | 0.03% | 585 |
|
2019
Q2 | $4.26M | Buy |
97,885
+54,088
| +123% | +$2.35M | 0.03% | 592 |
|
2019
Q1 | $1.67M | Buy |
43,797
+7,200
| +20% | +$274K | 0.01% | 781 |
|
2018
Q4 | $1.57M | Sell |
36,597
-57,203
| -61% | -$2.46M | 0.01% | 751 |
|
2018
Q3 | $4.61M | Sell |
93,800
-24,700
| -21% | -$1.21M | 0.04% | 459 |
|
2018
Q2 | $3.8M | Buy |
118,500
+108,000
| +1,029% | +$3.46M | 0.03% | 560 |
|
2018
Q1 | $327K | Buy |
+10,500
| New | +$327K | ﹤0.01% | 1176 |
|